Literature DB >> 26526530

Bumetanide for neonatal seizures-back from the cotside.

Ronit M Pressler1, Geraldine B Boylan2, Neil Marlow1, Linda S de Vries3, Mats Blennow4, Catherine Chiron5,6, J Helen Cross1, Boubou Hallberg4, Lena Hellström-Westas7, Vincent Jullien5,6, Barry Mangum8, Brendan Murphy2, Deirdre Murray2, Gerard Pons5,6, Janet Rennie1, Mona C Toet9, Sarah Zohar10.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26526530     DOI： 10.1038/nrneurol.2015.116

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  11 in total

1.  Optimal designs for estimating the most successful dose.

Authors:  Sarah Zohar; John O'Quigley
Journal:  Stat Med       Date:  2006-12-30       Impact factor: 2.373

Review 2.  Potential benefit of Bayesian forecasting for therapeutic drug monitoring in neonates.

Authors:  Gérard Pons; Jean-Marc Tréluyer; Jérôme Dimet; Yann Merlé
Journal:  Ther Drug Monit       Date:  2002-02       Impact factor: 3.681

3.  Sensorineural hearing loss and prematurity.

Authors:  E S Marlow; L P Hunt; N Marlow
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

4.  Factors associated with permanent hearing impairment in infants treated with therapeutic hypothermia.

Authors:  Elisa Smit; Xun Liu; Hannah Gill; Hemmen Sabir; Sally Jary; Marianne Thoresen
Journal:  J Pediatr       Date:  2013-07-23       Impact factor: 4.406

5.  Bumetanide for the treatment of seizures in newborn babies with hypoxic ischaemic encephalopathy (NEMO): an open-label, dose finding, and feasibility phase 1/2 trial.

Authors:  Ronit M Pressler; Geraldine B Boylan; Neil Marlow; Mats Blennow; Catherine Chiron; J Helen Cross; Linda S de Vries; Boubou Hallberg; Lena Hellström-Westas; Vincent Jullien; Vicki Livingstone; Barry Mangum; Brendan Murphy; Deirdre Murray; Gerard Pons; Janet Rennie; Renate Swarte; Mona C Toet; Sampsa Vanhatalo; Sarah Zohar
Journal:  Lancet Neurol       Date:  2015-03-10       Impact factor: 44.182

6.  Epilepsy: Neonatal seizures still lack safe and effective treatment.

Authors:  Marianne Thoresen; Hemmen Sabir
Journal:  Nat Rev Neurol       Date:  2015-04-28       Impact factor: 42.937

7.  Therapeutic hypothermia in neonatal hypoxic ischemic encephalopathy: electrographic seizures and magnetic resonance imaging evidence of injury.

Authors:  Preethi Srinivasakumar; John Zempel; Michael Wallendorf; Russell Lawrence; Terrie Inder; Amit Mathur
Journal:  J Pediatr       Date:  2013-02-26       Impact factor: 4.406

Review 8.  Cooling for newborns with hypoxic ischaemic encephalopathy.

Authors:  Susan E Jacobs; Marie Berg; Rod Hunt; William O Tarnow-Mordi; Terrie E Inder; Peter G Davis
Journal:  Cochrane Database Syst Rev       Date:  2013-01-31

9.  Bumetanide hyperpolarizes madin-darby canine kidney cells and enhances cellular gentamicin uptake by elevating cytosolic Ca(2+) thus facilitating intermediate conductance Ca(2+)--activated potassium channels.

Authors:  Tian Wang; Yu-Qin Yang; Takatoshi Karasawa; Qi Wang; Amanda Phillips; Bing-Cai Guan; Ke-Tao Ma; Meiyan Jiang; Ding-Hua Xie; Peter S Steyger; Zhi-Gen Jiang
Journal:  Cell Biochem Biophys       Date:  2013-04       Impact factor: 2.194

10.  Age- and sex-dependent susceptibility to phenobarbital-resistant neonatal seizures: role of chloride co-transporters.

Authors:  Seok Kyu Kang; Geoffrey J Markowitz; Shin Tae Kim; Michael V Johnston; Shilpa D Kadam
Journal:  Front Cell Neurosci       Date:  2015-05-12       Impact factor: 5.505
View more
  9 in total

1.  Pharmaco-resistant Neonatal Seizures: Critical Mechanistic Insights from a Chemoconvulsant Model.

Authors:  Shivani C Kharod; Brandon M Carter; Shilpa D Kadam
Journal:  Dev Neurobiol       Date:  2018-08-31       Impact factor: 3.964

Review 2.  Acute symptomatic seizures in term neonates: Etiologies and treatments.

Authors:  Janet S Soul
Journal:  Semin Fetal Neonatal Med       Date:  2018-02-06       Impact factor: 3.926

Review 3.  Recent Advances in Neonatal Seizures.

Authors:  Tristan T Sands; Tiffani L McDonough
Journal:  Curr Neurol Neurosci Rep       Date:  2016-10       Impact factor: 5.081

Review 4.  Chloride Dysregulation, Seizures, and Cerebral Edema: A Relationship with Therapeutic Potential.

Authors:  Joseph Glykys; Volodymyr Dzhala; Kiyoshi Egawa; Kristopher T Kahle; Eric Delpire; Kevin Staley
Journal:  Trends Neurosci       Date:  2017-04-18       Impact factor: 13.837

Review 5.  Pharmacotherapy for Neonatal Seizures: Current Knowledge and Future Perspectives.

Authors:  Maria D Donovan; Brendan T Griffin; Liudmila Kharoshankaya; John F Cryan; Geraldine B Boylan
Journal:  Drugs       Date:  2016-04       Impact factor: 9.546

6.  The Anti-inflammatory Compound Candesartan Cilexetil Improves Neurological Outcomes in a Mouse Model of Neonatal Hypoxia.

Authors:  Sean Quinlan; Paula Merino-Serrais; Alessandra Di Grande; Heiko Dussmann; Jochen H M Prehn; Tríona Ní Chonghaile; David C Henshall; Eva M Jimenez-Mateos
Journal:  Front Immunol       Date:  2019-07-24       Impact factor: 7.561

7.  Restoring neuronal chloride homeostasis with anti-NKCC1 gene therapy rescues cognitive deficits in a mouse model of Down syndrome.

Authors:  Martina Parrini; Shovan Naskar; Micol Alberti; Ilaria Colombi; Giovanni Morelli; Anna Rocchi; Marina Nanni; Federica Piccardi; Severine Charles; Giuseppe Ronzitti; Federico Mingozzi; Andrea Contestabile; Laura Cancedda
Journal:  Mol Ther       Date:  2021-05-29       Impact factor: 12.910

8.  Inhibition of CK2 mitigates Alzheimer's tau pathology by preventing NR2B synaptic mislocalization.

Authors:  Courtney A Marshall; Jennifer D McBride; Lakshmi Changolkar; Dawn M Riddle; John Q Trojanowski; Virginia M-Y Lee
Journal:  Acta Neuropathol Commun       Date:  2022-03-04       Impact factor: 7.801

9.  Epilepsy Benchmarks Area III: Improved Treatment Options for Controlling Seizures and Epilepsy-Related Conditions Without Side Effects.

Authors:  Stephen F Traynelis; Dennis Dlugos; David Henshall; Heather C Mefford; Michael A Rogawski; Kevin J Staley; Penny A Dacks; Vicky Whittemore; Annapurna Poduri
Journal:  Epilepsy Curr       Date:  2020-01-22       Impact factor: 7.500
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.